ITDompé
RESEARCH, DEVELOPMENT AND PRODUCTION
Dompé is a privately owned biopharmaceutical company with 130 years of experience. Headquartered in Milan, we operate in Boston, San Francisco, and Shanghai. Dompé is committed to medical and scientific advancement, through our own research and open innovation ecosystem.
PRIMARY CARE
Prescription drugs and OTC products, dietary supplements, medical devices and cosmetics
BIOTECH
Treatment of rare diseases with no approved treatment
We conduct our research activities as part of a network of over 300 centers and universities across the world that has performed 27 clinical trials for more than 2000 patients.
Discover our research
Discover our production hub
THERAPEUTIC AREAS
Diabetes, Opthalmology, and conditions with high unmet need
800
Total employees
532 Mln
Revenues in euro (2020)
REACH
Europe, United States, China
60 MILLION
Packages manufactured in 2020
8
Production lines (7 synthesis, 1 biotech)
CDMO
Synthesis and biotech
BIOTECH APPROVALS
EMA (European Medicines Agency), Europe
FDA (Food and Drug Administration), United States
NMPA (National Medical Products Administration), China
BIOTECH
We have developed the first application of rhNGF (recombinant human Nerve Growth Factor) as a commercial therapy. Dompé's
rhNGF is the first and only pharmacologic treatment specifically indicated for Neurotrophic Keratitis, approved by the FDA and EMA.
-
2017
Year of marketing authorization granted by the EMA in Europe and granted breakthrough, fast track and priority review designations by FDA in the US
-
2018
FDA approval
-
2019
Chinese National Medical Products Administration (NMPA) inclusion among the 40 clinically needed drugs overseas
-
2020
Expected NMPA marketking authorization
HISTORY
Dompé farmaceutici is established in 1940, stemming from a pharmacological roots dating back to the Nineteenth Century
-
1870-1890
Gian Antonio Dompé devotes himself to studying chemical-pharmaceutical sciences and eventually becomes a science savant.
-
1895
Onorato Dompé, Gian Antonio’s son, establishes the Dompé-Adami laboratory in Milan.
-
1924
Onorato Dompé establishes the first pharmaceutical production plant in Milan.
-
1940
Franco Dompé, Onorato’s son, founds Dompé farmaceutici in Milan.
- WHO WE ARE
- Dompé at a glance
- History
- Management
- Dompé Holdings
- Where we are
- RESEARCH AND INNOVATION
- Research and development
- Drug discovery
- R&D pipeline
- Publications
- Clinical studies
- PRODUCTION HUB
- Production plant
- Biotech production
- Pharma production
- RESPONSIBILITY
- Ethics
- Transparency
- Patient associations
- CAREERS
- Working at Dompé
- Open positions
dompe.us
dompechina.com